Ep. 07: Use of T cell receptors (TCR’s) as immunotherapy against cancer Podcast Por  arte de portada

Ep. 07: Use of T cell receptors (TCR’s) as immunotherapy against cancer

Ep. 07: Use of T cell receptors (TCR’s) as immunotherapy against cancer

Escúchala gratis

Ver detalles del espectáculo

Acerca de esta escucha

In this episode we interview Dr. Johanna Olweus and Dr. Morten Milek Nielsen from University of Oslo about the use of T cell receptors (TCR’s) as immunotherapy against cancer.

Dr. Olweus’s group has been speadheading identifying TCRs that are specific for minute mutations in cancer cells, that can be used in adoptive T-cell-based therapies. We talk about what the therapy entails, how TCRs are discovered and go through several papers her group has published recently on using TCR-based therapies against leukemia.

The articles discussed are:

- “Induction of neoantigen-reactive T cells from healthy donors” (link: https://pubmed.ncbi.nlm.nih.gov/31101906/)

- “T cells targeted to TdT kill leukemic lymphoblasts while sparing normal lymphocytes” (Link: https://www.nature.com/articles/s41587-021-01089-x)

- “A T cell receptor targeting a recurrent driver mutation in FLT3 mediates elimination of primary human acute myeloid leukemia in vivo” (Link: https://www.nature.com/articles/s43018-023-00642-8)

- “A systematic safety pipeline for selection of T-cell receptors to enter clinical use” (Link: https://pubmed.ncbi.nlm.nih.gov/37607971/)


You can read more about Dr. Olweus research group here: https://www.ous-research.no/olweus/

Todavía no hay opiniones